These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 24516603

  • 1. Obscurins: Goliaths and Davids take over non-muscle tissues.
    Ackermann MA, Shriver M, Perry NA, Hu LY, Kontrogianni-Konstantopoulos A.
    PLoS One; 2014; 9(2):e88162. PubMed ID: 24516603
    [Abstract] [Full Text] [Related]

  • 2. The kinase domains of obscurin interact with intercellular adhesion proteins.
    Hu LY, Kontrogianni-Konstantopoulos A.
    FASEB J; 2013 May; 27(5):2001-12. PubMed ID: 23392350
    [Abstract] [Full Text] [Related]

  • 3. Binding of an ankyrin-1 isoform to obscurin suggests a molecular link between the sarcoplasmic reticulum and myofibrils in striated muscles.
    Bagnato P, Barone V, Giacomello E, Rossi D, Sorrentino V.
    J Cell Biol; 2003 Jan 20; 160(2):245-53. PubMed ID: 12527750
    [Abstract] [Full Text] [Related]

  • 4. Loss of giant obscurins promotes breast epithelial cell survival through apoptotic resistance.
    Perry NA, Shriver M, Mameza MG, Grabias B, Balzer E, Kontrogianni-Konstantopoulos A.
    FASEB J; 2012 Jul 20; 26(7):2764-75. PubMed ID: 22441987
    [Abstract] [Full Text] [Related]

  • 5. Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathway.
    Ackermann MA, King B, Lieberman NAP, Bobbili PJ, Rudloff M, Berndsen CE, Wright NT, Hecker PA, Kontrogianni-Konstantopoulos A.
    J Mol Cell Cardiol; 2017 Oct 20; 111():27-39. PubMed ID: 28826662
    [Abstract] [Full Text] [Related]

  • 6. Obscurins: unassuming giants enter the spotlight.
    Perry NA, Ackermann MA, Shriver M, Hu LY, Kontrogianni-Konstantopoulos A.
    IUBMB Life; 2013 Jun 20; 65(6):479-86. PubMed ID: 23512348
    [Abstract] [Full Text] [Related]

  • 7. Obscurin, a giant sarcomeric Rho guanine nucleotide exchange factor protein involved in sarcomere assembly.
    Young P, Ehler E, Gautel M.
    J Cell Biol; 2001 Jul 09; 154(1):123-36. PubMed ID: 11448995
    [Abstract] [Full Text] [Related]

  • 8. Molecular interactions with obscurin are involved in the localization of muscle-specific small ankyrin1 isoforms to subcompartments of the sarcoplasmic reticulum.
    Armani A, Galli S, Giacomello E, Bagnato P, Barone V, Rossi D, Sorrentino V.
    Exp Cell Res; 2006 Nov 01; 312(18):3546-58. PubMed ID: 16962094
    [Abstract] [Full Text] [Related]

  • 9. The rho-guanine nucleotide exchange factor domain of obscurin activates rhoA signaling in skeletal muscle.
    Ford-Speelman DL, Roche JA, Bowman AL, Bloch RJ.
    Mol Biol Cell; 2009 Sep 01; 20(17):3905-17. PubMed ID: 19605563
    [Abstract] [Full Text] [Related]

  • 10. Obscure functions: the location-function relationship of obscurins.
    Manring HR, Carter OA, Ackermann MA.
    Biophys Rev; 2017 Jun 01; 9(3):245-258. PubMed ID: 28510116
    [Abstract] [Full Text] [Related]

  • 11. Obscurin interacts with a novel isoform of MyBP-C slow at the periphery of the sarcomeric M-band and regulates thick filament assembly.
    Ackermann MA, Hu LY, Bowman AL, Bloch RJ, Kontrogianni-Konstantopoulos A.
    Mol Biol Cell; 2009 Jun 01; 20(12):2963-78. PubMed ID: 19403693
    [Abstract] [Full Text] [Related]

  • 12. Giant obscurin regulates migration and metastasis via RhoA-dependent cytoskeletal remodeling in pancreatic cancer.
    Tuntithavornwat S, Shea DJ, Wong BS, Guardia T, Lee SJ, Yankaskas CL, Zheng L, Kontrogianni-Konstantopoulos A, Konstantopoulos K.
    Cancer Lett; 2022 Feb 01; 526():155-167. PubMed ID: 34826548
    [Abstract] [Full Text] [Related]

  • 13. Unraveling obscurins in heart disease.
    Grogan A, Kontrogianni-Konstantopoulos A.
    Pflugers Arch; 2019 May 01; 471(5):735-743. PubMed ID: 30099631
    [Abstract] [Full Text] [Related]

  • 14. Giant obscurins regulate the PI3K cascade in breast epithelial cells via direct binding to the PI3K/p85 regulatory subunit.
    Shriver M, Marimuthu S, Paul C, Geist J, Seale T, Konstantopoulos K, Kontrogianni-Konstantopoulos A.
    Oncotarget; 2016 Jul 19; 7(29):45414-45428. PubMed ID: 27323778
    [Abstract] [Full Text] [Related]

  • 15. The complete gene sequence of titin, expression of an unusual approximately 700-kDa titin isoform, and its interaction with obscurin identify a novel Z-line to I-band linking system.
    Bang ML, Centner T, Fornoff F, Geach AJ, Gotthardt M, McNabb M, Witt CC, Labeit D, Gregorio CC, Granzier H, Labeit S.
    Circ Res; 2001 Nov 23; 89(11):1065-72. PubMed ID: 11717165
    [Abstract] [Full Text] [Related]

  • 16. Obscurin targets ankyrin-B and protein phosphatase 2A to the cardiac M-line.
    Cunha SR, Mohler PJ.
    J Biol Chem; 2008 Nov 14; 283(46):31968-80. PubMed ID: 18782775
    [Abstract] [Full Text] [Related]

  • 17. Obscurin: A multitasking giant in the fight against cancer.
    Guardia T, Eason M, Kontrogianni-Konstantopoulos A.
    Biochim Biophys Acta Rev Cancer; 2021 Aug 14; 1876(1):188567. PubMed ID: 34015411
    [Abstract] [Full Text] [Related]

  • 18. Obscurin regulates the organization of myosin into A bands.
    Kontrogianni-Konstantopoulos A, Catino DH, Strong JC, Randall WR, Bloch RJ.
    Am J Physiol Cell Physiol; 2004 Jul 14; 287(1):C209-17. PubMed ID: 15013951
    [Abstract] [Full Text] [Related]

  • 19. Obscurin: a multitasking muscle giant.
    Kontrogianni-Konstantopoulos A, Bloch RJ.
    J Muscle Res Cell Motil; 2005 Jul 14; 26(6-8):419-26. PubMed ID: 16625317
    [Abstract] [Full Text] [Related]

  • 20. Loss of giant obscurins from breast epithelium promotes epithelial-to-mesenchymal transition, tumorigenicity and metastasis.
    Shriver M, Stroka KM, Vitolo MI, Martin S, Huso DL, Konstantopoulos K, Kontrogianni-Konstantopoulos A.
    Oncogene; 2015 Aug 06; 34(32):4248-59. PubMed ID: 25381817
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.